Area of research
Otorhinolaryngology · Radiation
Research interest
Research focused on Head and neck and Head and neck cancer, with related work in Larynx, Radiation therapy, Chemoradiotherapy. Notable publications include 'Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology', '2021 American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid Cancer', and 'NCCN Guidelines Insights: Head and Neck Cancers, Version 1.2018'.
Proton versus photon radiotherapy for patients with oropharyngeal cancer in the USA: a multicentre, randomised, open-label, non-inferiority phase 3 trial
Phase III randomized trial of intensity-modulated proton therapy (IMPT) versus intensity-modulated photon therapy (IMRT) for the treatment of head and neck oropharyngeal carcinoma (OPC).
Radiotherapy and paclitaxel plus pazopanib or placebo in anaplastic thyroid cancer (NRG/RTOG 0912): a randomised, double-blind, placebo-controlled, multicentre, phase 2 trial
Pragmatic, Prospective Comparative Effectiveness Trial of Carbon Ion Therapy, Surgery, and Proton Therapy for the Management of Pelvic Sarcomas (Soft Tissue/Bone) Involving the Bone: The PROSPER Study Rationale and Design
2021 American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid Cancer
Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology
Precision Radiotherapy: Reduction in Radiation for Oropharyngeal Cancer in the 30 ROC Trial
NCCN Guidelines Insights: Head and Neck Cancers, Version 1.2018
NCCN Guidelines Insights: Head and Neck Cancers, Version 2.2017
Establishing quality indicators for neck dissection: Correlating the number of lymph nodes with oncologic outcomes (NRG Oncology RTOG 9501 and RTOG 0234)
Correlation Between the Severity of Cetuximab-Induced Skin Rash and Clinical Outcome for Head and Neck Cancer Patients: The RTOG Experience
Head and Neck Cancers, Version 1.2015
Establishing quality indicators for neck dissection: Correlating the number of lymph nodes with oncologic outcomes, NRG Oncology/RTOG 9501-0234.
Postoperative Chemoradiotherapy and Cetuximab for High-Risk Squamous Cell Carcinoma of the Head and Neck: Radiation Therapy Oncology Group RTOG-0234
State-of-the-art treatment alternatives for base of skull meningiomas: complementing and controversial indications for neurosurgery, stereotactic and robotic based radiosurgery or modern fractionated radiation techniques